Enobosarm is a small molecule commercialized by Veru, with a leading Phase II program in Obesity. According to Globaldata, it is involved in 20 clinical trials, of which 14 were completed, 1 is ...
A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay ...
oestrogen receptor-positive (ER+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer. The combination demonstrated a tolerable safety profile, as per the ongoing trial’s ...
Researchers have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a new study. The findings hold ...
Lund, Sweden, November 27, 2024 - Alligator Bioscience today announced that the Company was notified that the first patient has been dosed in a Phase 3 clinical trial with Shanghai Henlius Biotech, ...
A former model who killed her husband and then herself in a suspected murder-suicide displayed several "red flags", the victim's family said. Sabrina Krasniqi, 27, murdered her husband Pajtim ...